Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiang J Li

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2003
Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancerYouzhi Li, Xiangao Sun, J Thomas LaMont, et al.
Nucleic Acid Therapeutics|February 18, 2014
Target gene abundance contributes to the efficiency of siRNA-mediated gene silencingSun Woo Hong, Yuanyuan Jiang, Soyoun Kim, et al.
Plos One|August 29, 2012
Ionizing radiation induces stemness in cancer cellsLaura Ghisolfi, Andrew C Keates, Xingwang Hu, et al.
Pharmacogenomics|February 5, 2008
Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeuticsAndrew C Keates, Johannes H Fruehauf, Shuanglin Xiang, et al.
Journal of Biomolecular Screening|June 21, 2008
High-content fluorescent-based assay for screening activators of DNA damage checkpoint pathwaysBin Zhang, Xiubin Gu, Uma Uppalapati, et al.
International Journal of Oncology|March 4, 2010
Carvedilol in glioma treatment alone and with imatinib in vitroMine Erguven, Nuray Yazihan, Esin Aktas, et al.
Cancer Research|July 19, 2005
Dual induction of apoptosis and senescence in cancer cells by Chk2 activation: checkpoint activation as a strategy against cancerChang-Rung Chen, Wenxian Wang, Harry A Rogoff, et al.
Nucleic Acid Therapeutics|July 14, 2011
Long double-stranded RNA-mediated RNA interference and immunostimulation: long interfering double-stranded RNA as a potent anticancer therapeuticsChan Il Chang, Tae Yeon Lee, Pooja Dua, et al.
Nucleic Acid Therapeutics|July 14, 2011
Structural diversity repertoire of gene silencing small interfering RNAsChan Il Chang, Helena Andrade Kim, Pooja Dua, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 24, 2009
In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi)Shuanglin Xiang, Andrew C Keates, Johannes Fruehauf, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2003
Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancerYouzhi Li, Xiangao Sun, J Thomas LaMont, et al.
Nucleic Acid Therapeutics|February 18, 2014
Target gene abundance contributes to the efficiency of siRNA-mediated gene silencingSun Woo Hong, Yuanyuan Jiang, Soyoun Kim, et al.
Plos One|August 29, 2012
Ionizing radiation induces stemness in cancer cellsLaura Ghisolfi, Andrew C Keates, Xingwang Hu, et al.
Pharmacogenomics|February 5, 2008
Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeuticsAndrew C Keates, Johannes H Fruehauf, Shuanglin Xiang, et al.
Journal of Biomolecular Screening|June 21, 2008
High-content fluorescent-based assay for screening activators of DNA damage checkpoint pathwaysBin Zhang, Xiubin Gu, Uma Uppalapati, et al.
International Journal of Oncology|March 4, 2010
Carvedilol in glioma treatment alone and with imatinib in vitroMine Erguven, Nuray Yazihan, Esin Aktas, et al.
Cancer Research|July 19, 2005
Dual induction of apoptosis and senescence in cancer cells by Chk2 activation: checkpoint activation as a strategy against cancerChang-Rung Chen, Wenxian Wang, Harry A Rogoff, et al.
Nucleic Acid Therapeutics|July 14, 2011
Long double-stranded RNA-mediated RNA interference and immunostimulation: long interfering double-stranded RNA as a potent anticancer therapeuticsChan Il Chang, Tae Yeon Lee, Pooja Dua, et al.
Nucleic Acid Therapeutics|July 14, 2011
Structural diversity repertoire of gene silencing small interfering RNAsChan Il Chang, Helena Andrade Kim, Pooja Dua, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 24, 2009
In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi)Shuanglin Xiang, Andrew C Keates, Johannes Fruehauf, et al.
Pageof 3